Negar Nasri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Negar Nasri has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Ghasem Dini
Department of Nanotechnology, Faculty of Chemistry, University of Isfahan, Isfahan, Iran
9 shared publications Shaghayegh Saharkhiz
Department of Biotechnology, Faculty of Biological Science and Technology, University of Isfahan, Isfahan, 81746-73441, Iran
5 shared publicationsFereshteh Mahmoodiyan Najafabadi
Department of Nanotechnology, Faculty of Chemistry, University of Isfahan, Isfahan 81746-73441, Iran
2 shared publicationsHomeira Zare Chavoshy
2 shared publications- Saghar Yousefnia
Semnan University
2 shared publications - Afsaneh Marandi
Department of Chemistry, Catalysis Division, University of Isfahan, Isfahan 81746-73441, Iran
1 shared publication
Latest Publications
- Open Access
- 4 November 2026
- Published by Elsevier in Materials & Design
- Vol. 272
Thermosensitive PEGylated niosome-loaded dissolving microneedles for localized co-delivery of gemcitabine and paclitaxel in triple-negative breast cancer
- 4 November 2026
- Published by Elsevier in Materials & Design
- Vol. 272
Open AccessThermosensitive PEGylated niosome-loaded dissolving microneedles for localized co-delivery of gemcitabine and paclitaxel in triple-negative breast cancer
- Open Access
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
Apt19s-functionalized 3D-printed PCL/58S bioactive glass scaffolds via thiol–maleimide click chemistry enhance hBMSC adhesion and osteogenic differentiation
Thiol–maleimide click chemistry immobilized Apt19s aptamer on 3D-printed PCL/58S scaffolds. The Apt-functionalized scaffolds enhanced hBMSC adhesion and osteogenic differentiation, supporting bone tissue engineering.
- 1 January 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
Open AccessApt19s-functionalized 3D-printed PCL/58S bioactive glass scaffolds via thiol–maleimide click chemistry enhance hBMSC adhesion and osteogenic differentiation
Thiol–maleimide click chemistry immobilized Apt19s aptamer on 3D-printed PCL/58S scaffolds. The Apt-functionalized scaffolds enhanced hBMSC adhesion and osteogenic differentiation, supporting bone tissue engineering.
- 24 December 2025
- Published by IOP Publishing in Biomedical Physics & Engineering Express
- Vol. 12 (1) , 015031
Electrospun gelatin/PCL nanofibers incorporating curcumin loaded hydroxyapatite: a dual function antibacterial wound dressing for controlled drug release and accelerated skin repair
In the present study, electrospinning was used to create a new wound dressing consisting of hydroxyapatite nanoparticles, in which curcumin was encapsulated and prepared as a nanocomposite in gelatin and polycaprolactone solution. Physicochemical and biological properties of the prepared wound dressing were evaluated under laboratory conditions. The findings demonstrated that curcumin-HA increases the tensile strength and elongation at break while decreasing elastic modulus. In contrast, when the curcumin-HA structure was added to PCL, swelling capacity and degradation rate were significantly improved. In addition, a disk diffusion test on Staphylococcus aureus and Escherichia coli confirmed the effectiveness of the antibacterial properties of this wound dressing. In addition, sustained release of curcumin for up to 15 days was achieved in Gel (curcumin-HA)/PCL nanofibers which could be a positive option in the performance of this wound dressing. According to in vitro cell viability tests conducted on the L929 fibroblast cell line, the (curcumin-HA)/PCL gel nanofibers not only did not have cytotoxicity but also improved the cell repair process within three days, confirming their potential for use as wound dressings.
- 24 December 2025
- Published by IOP Publishing in Biomedical Physics & Engineering Express
- Vol. 12 (1) , 015031
Electrospun gelatin/PCL nanofibers incorporating curcumin loaded hydroxyapatite: a dual function antibacterial wound dressing for controlled drug release and accelerated skin repair
In the present study, electrospinning was used to create a new wound dressing consisting of hydroxyapatite nanoparticles, in which curcumin was encapsulated and prepared as a nanocomposite in gelatin and polycaprolactone solution. Physicochemical and biological properties of the prepared wound dressing were evaluated under laboratory conditions. The findings demonstrated that curcumin-HA increases the tensile strength and elongation at break while decreasing elastic modulus. In contrast, when the curcumin-HA structure was added to PCL, swelling capacity and degradation rate were significantly improved. In addition, a disk diffusion test on Staphylococcus aureus and Escherichia coli confirmed the effectiveness of the antibacterial properties of this wound dressing. In addition, sustained release of curcumin for up to 15 days was achieved in Gel (curcumin-HA)/PCL nanofibers which could be a positive option in the performance of this wound dressing. According to in vitro cell viability tests conducted on the L929 fibroblast cell line, the (curcumin-HA)/PCL gel nanofibers not only did not have cytotoxicity but also improved the cell repair process within three days, confirming their potential for use as wound dressings.
- Open Access
- 16 December 2025
- Published by Elsevier in Results in Engineering
- Vol. 29
Aptamer-conjugated 3d-printed hydroxyapatite/polycaprolactone scaffolds enhance osteogenic differentiation of human bone marrow-derived mesenchymal stem cells
- 16 December 2025
- Published by Elsevier in Results in Engineering
- Vol. 29
Open AccessAptamer-conjugated 3d-printed hydroxyapatite/polycaprolactone scaffolds enhance osteogenic differentiation of human bone marrow-derived mesenchymal stem cells
- Open Access
- 21 October 2025
- Published by IntechOpen
Microalgae in Medicine: Emerging Therapeutic Applications
Microalgae, as prolific producers of bioactive metabolites, have emerged as promising candidates in the development of novel therapeutic agents. These unicellular photosynthetic organisms synthesize a diverse array of primary and secondary metabolites—including carotenoids, phycobiliproteins, polyunsaturated fatty acids (PUFAs), sulfated polysaccharides, and phenolic compounds—that exhibit potent pharmacological activities. Accumulating evidence from preclinical models and early-stage clinical trials supports their anti-inflammatory, antioxidant, immunomodulatory, anticancer, neuroprotective, and cardioprotective properties. Compounds such as astaxanthin, fucoxanthin, C-phycocyanin, and eicosapentaenoic acid (EPA)/docosahexaenoic acid (DHA) have demonstrated the ability to modulate critical signaling pathways, including NF-κB, Nrf2, MAPK, and JAK/STAT, thereby attenuating pro-inflammatory cytokine production, reducing oxidative stress, and inhibiting apoptosis in various disease models, including cancer, cardiovascular dysfunction, and neurodegenerative disorders. In parallel, sulfated polysaccharides and sulfolipids extracted from microalgae have shown immunoregulatory functions through macrophage activation, regulation of cytokine profiles, and interaction with innate immune receptors such as TLRs and Dectin-1. Advances in biotechnological tools, including high-throughput screening, omics technologies, and green extraction methodologies, have significantly facilitated the identification and production of these bioactive compounds. However, challenges related to standardization, scalability, pharmacokinetics, and regulatory validation remain major obstacles in the clinical translation of microalgae-based therapeutics.
- 21 October 2025
- Published by IntechOpen
Open AccessMicroalgae in Medicine: Emerging Therapeutic Applications
Microalgae, as prolific producers of bioactive metabolites, have emerged as promising candidates in the development of novel therapeutic agents. These unicellular photosynthetic organisms synthesize a diverse array of primary and secondary metabolites—including carotenoids, phycobiliproteins, polyunsaturated fatty acids (PUFAs), sulfated polysaccharides, and phenolic compounds—that exhibit potent pharmacological activities. Accumulating evidence from preclinical models and early-stage clinical trials supports their anti-inflammatory, antioxidant, immunomodulatory, anticancer, neuroprotective, and cardioprotective properties. Compounds such as astaxanthin, fucoxanthin, C-phycocyanin, and eicosapentaenoic acid (EPA)/docosahexaenoic acid (DHA) have demonstrated the ability to modulate critical signaling pathways, including NF-κB, Nrf2, MAPK, and JAK/STAT, thereby attenuating pro-inflammatory cytokine production, reducing oxidative stress, and inhibiting apoptosis in various disease models, including cancer, cardiovascular dysfunction, and neurodegenerative disorders. In parallel, sulfated polysaccharides and sulfolipids extracted from microalgae have shown immunoregulatory functions through macrophage activation, regulation of cytokine profiles, and interaction with innate immune receptors such as TLRs and Dectin-1. Advances in biotechnological tools, including high-throughput screening, omics technologies, and green extraction methodologies, have significantly facilitated the identification and production of these bioactive compounds. However, challenges related to standardization, scalability, pharmacokinetics, and regulatory validation remain major obstacles in the clinical translation of microalgae-based therapeutics.
- Open Access
- 17 September 2025
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 15 (41) , 34481-34509
Metal–organic frameworks for biomedical applications: bridging materials science and regenerative medicine
This review explores the biomedical applications of metal–organic frameworks (MOFs), focusing on their potential in bone regeneration.
- 17 September 2025
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 15 (41) , 34481-34509
Open AccessMetal–organic frameworks for biomedical applications: bridging materials science and regenerative medicine
This review explores the biomedical applications of metal–organic frameworks (MOFs), focusing on their potential in bone regeneration.
- 6 July 2024
- Published by Elsevier in Fish & Shellfish Immunology
- Vol. 151, 109754
Synthesis of alga-coated copper oxide nanoparticles with potential applications in shrimp farming
- 6 July 2024
- Published by Elsevier in Fish & Shellfish Immunology
- Vol. 151, 109754
Synthesis of alga-coated copper oxide nanoparticles with potential applications in shrimp farming